NCT05108805 2025-03-27
Chimeric Antigen Receptor (CAR) T Cell Therapy With YESCARTA in the Outpatient Setting
Vanderbilt-Ingram Cancer Center
Phase 4 Completed
Vanderbilt-Ingram Cancer Center
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Goethe University
Goethe University
H. Lee Moffitt Cancer Center and Research Institute
PETHEMA Foundation
PETHEMA Foundation